Although it is still unclear whether high or low levels of anti-apoptotic Bcl-2 proteins in CTCs is correlated with breast cancer metastasis in humans [94,95], mice intravenously injected with MDA-MB-435 breast cancer cells overexpressing Bcl-xL increased formation of secondary tumors [102]. The gene discussed is BCL2L1; the disease is breast carcinoma.